DEA Archived Press Releases

Press Releases before January 20, 2025
9 Results - Showing 1 to 9
PRESS RELEASE

UT Southwestern to Pay $4.5 Million to Resolve Alleged Controlled Substance Act Violations That Permitted Drug Diversion by Staff

Dallas - The University of Texas Southwestern Medical Center has agreed to pay $4.5 million to resolve allegations that its violations of the Controlled Substances Act allowed hospital staff to divert fentanyl and other dangerous drugs from the hospital, announced DEA Dallas Special Agent in Charge, Eduardo A. Chávez. The...
PRESS RELEASE

Man Indicted for Taking Controlled Substances from Kansas Hospital

KANSAS CITY, Kan. – A federal grand jury in Kansas returned an indictment charging an Overland Park, Kansas, man on two counts of tampering with a consumer product, one count of possession of fentanyl by deception and subterfuge, and one count of possession of hydromorphone by deception and subterfuge. According...
PRESS RELEASE

Missouri Woman Indicted for Tampering with Hospitals’ Fentanyl

KANSAS CITY, Kan. – A federal grand jury in Kansas City, Kansas, returned an indictment charging a nurse from Kansas City, Missouri, with two counts of tampering with a consumer product and two counts of possession of fentanyl by deception and subterfuge. According to court documents, between January 2020 and...
PRESS RELEASE

Physician Assistant Sentenced for Conspiring to Distribute and Dispense Oxycodone, Fentanyl, Methadone, and Alprazolam

Baltimore, Md., – U.S. District Judge Richard D. Bennett sentenced William Soyke, age 68, of Hanover, Pennsylvania to 37 months in federal prison, followed by three years of supervised release, for conspiracy to distribute and dispense oxycodone, fentanyl, methadone, and alprazolam outside the scope of professional practice and not for...
PRESS RELEASE

Albany Doctor Admits to Violating the Controlled Substance Act

ALBANY, NY – Dr. Larry Bruni has agreed to pay the United States $50,000 to resolve allegations that on numerous occasions from 2016 through 2020, he prescribed controlled substances without a legitimate medical purpose or outside the usual course of a professional medical practice, in violation of the Controlled Substances...
PRESS RELEASE

Two Chicago Area Physicians Indicted on Narcotics and Health Care Fraud

CHICAGO — Special Agent in Charge Robert J. Bell, Drug Enforcement Administration-Chicago Division and John R. Lausch, Jr., United States Attorney for the Northern District of Illinois announced that two suburban Chicago physicians have been indicted on federal criminal charges for allegedly prescribing opioids to individuals who lacked a legitimate...
PRESS RELEASE

DEA Washington Division Issues Warning: “One Pill Can Kill”

Washington, D.C. – Jarod Forget, Special Agent in Charge (SAC) of the DEA Washington Division, is alerting all area residents to an increase in drug overdose deaths tied to counterfeit pills containing the powerful synthetic opioid, fentanyl. Manufactured by Mexican drug trafficking organizations, and marketed as a medication such as...
PRESS RELEASE

Three Indicted on Federal Drug Distribution Charges

CHARLOTTESVILLE, Va. – A husband and wife from Fairfax and their cousin from Spotsylvania were indicted last month for conspiring to distribute controlled substances in Virginia. According to court documents, Fahid Rashid, 30, Akhter Ahmed, 28, and Khalisah Khan, 29, conspired to traffic counterfeit pills containing fentanyl. The defendants, and...
PRESS RELEASE

Justice Department files lawsuit against Creve Coeur pharmacist for Controlled Substances Act violations

ST. LOUIS – In a complaint filed February 23, 2021, by the U.S. Attorney’s Office for the Eastern District of Missouri, the government alleges Elizabeth Dembo unlawfully dispensed controlled substances to patients during her time as the pharmacist-in-charge of Olive Street Pharmacy, LLC. The retail pharmacy is located in the...